表紙
市場調查報告書

全球腫瘤消融市場:規模,佔有率,趨勢,行業分析和細分市場預測(2020-2026)

Tumor Ablation Market Size, Share, Trends & Industry Analysis By Type Of Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others); By Mode Of Treatment ; By Application ; By Regions, Segment Forecast, 2020 - 2026

出版商 Polaris Market Research 商品編碼 953066
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
全球腫瘤消融市場:規模,佔有率,趨勢,行業分析和細分市場預測(2020-2026) Tumor Ablation Market Size, Share, Trends & Industry Analysis By Type Of Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others); By Mode Of Treatment ; By Application ; By Regions, Segment Forecast, 2020 - 2026
出版日期: 2020年03月01日內容資訊: 英文 120 Pages
簡介

到2026年,全球腫瘤消融市場預計將達到24億美元。消融是一種無需清除即可消滅肝腫瘤的治療方法。

全球腫瘤消融市場正經歷著越來越多的各種形式的癌症發生,腫瘤消融領域中用於癌症治療的技術進步以及人們對消融手術相對於傳統外科手術的益處的認識不斷提高。是由因素促進的。此外,消融中心,手術中心和醫院的增長正在推動全球腫瘤消融市場的增長。此外,消融專業知識的不斷發展導致高效,安全和微創的新型,開創性產品的開發增加,導致全球腫瘤消融市場顯著增長。

隨著老年人口的增長,全球對微創手術(MIS)的需求正在增加。微創手術使患者的恢復速度比傳統的侵入性手術快。因此,對諸如射頻消融和冷凍消融的微創手術的需求增加了,這加速了全球市場的增長。

該報告調查了全球腫瘤消融市場,並探討了市場機遇和挑戰,增長和限制,行業趨勢,技術類型,治療方法,應用,區域市場分析,競爭格局和主要參與者。我們提供諸如您的個人資料之類的信息。

目錄

第1章概述和範圍

  • 調查目的和範圍
  • 調查的先決條件
  • 調查方法
    • 主要數據源
    • 輔助數據源
  • 重點
  • 利益相關者

第2章執行摘要

  • 市場定義
  • 市場細分

第3章腫瘤消融市場的思考

  • 腫瘤消融工業快照
  • 腫瘤消融-生態系統分析
  • 腫瘤消融市場動態
    • 腫瘤消融-市場動態
    • 行業分析-波特的五種力量
    • 腫瘤消融市場PEST分析,2019年
    • 價值鏈分析
    • 腫瘤消融行業的發展趨勢
    • 腫瘤消融的發生率

第4章按技術類型劃分的市場規模和預測

  • 主要發現
  • 射頻(RF)消融
    • 2020-2026年世界市場估計和預測
  • 微波消融
    • 2020-2026年世界市場估計和預測
  • 冷凍消融
    • 2020-2026年世界市場估計和預測
  • 其他
    • 2020-2026年世界市場估計和預測

第5章市場規模和治療方法預測

  • 主要發現
  • 手術消融
    • 2020-2026年世界市場估計和預測
  • 腹腔鏡消融
    • 2020-2026年世界市場估計和預測
  • 經皮消融
    • 2020-2026年世界市場估計和預測

第6章市場規模和按應用預測

  • 主要發現
  • 肝癌
    • 2020-2026年世界市場估計和預測
  • 肺癌
    • 2020-2026年世界市場估計和預測
  • 腎臟癌
    • 2020-2026年世界市場估計和預測
  • 骨轉移
    • 2020-2026年世界市場估計和預測
  • 其他
    • 2020-2026年世界市場估計和預測

第7章按地區劃分的市場規模和預測

  • 主要發現
  • 北美
    • 按技術類型劃分的腫瘤消融市場(百萬美元),2020-2026年
    • 按治療方法劃分的腫瘤消融市場(百萬美元),2020-2026
    • 按應用分列的腫瘤消融市場(百萬美元),2020-2026
    • 美國
    • 加拿大
  • 歐洲
    • 2020-2026年按技術類型劃分的市場(百萬美元)
    • 按治療方法劃分的腫瘤消融市場(百萬美元),2020-2026
    • 按應用分列的市場(百萬美元),2020-2026
    • 德國
    • 英國
  • 亞太地區
    • 2020-2026年按技術類型劃分的市場(百萬美元)
    • 按處理方法劃分的市場(百萬美元),2020-2026
    • 按應用分列的市場(百萬美元),2020-2026
    • 中國
    • 印度
    • 日本
  • 拉丁美洲
    • 2020-2026年按技術類型劃分的市場(百萬美元)
    • 按處理方法劃分的市場(百萬美元),2020-2026
    • 按應用分列的市場(百萬美元),2020-2026
    • 巴西
    • 墨西哥
  • 中東/非洲
    • 2020-2026年按技術類型劃分的市場(百萬美元)
    • 按處理方法劃分的市場(百萬美元),2020-2026
    • 按應用分列的市場(百萬美元),2020-2026

第8章公司簡介

  • EDAP TMS S.A.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • Jude Medical Inc.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • BVM Medical Ltd.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • SonaCare Medical LLC
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • AngioDynamics Inc.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • Boston Scientific Corp.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • Pacific Biosciences of California, Inc
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • BTG International Ltd.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
  • Integra Life Sciences Holdings Corp.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
  • Medtronic plc.
    • 概述
    • 財務概覽
    • 對產品類型進行基準測試
    • 最新趨勢
目錄
Product Code: PM1214

Title:
Tumor Ablation Market Size, Share, Trends & Industry Analysis By Type Of Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, and Others); By Mode Of Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation); By Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others); By Regions, Segment Forecast, 2020 - 2026.

The global tumor ablation market is anticipated to reach USD 2.4 billion by 2026 according to a new study published by Polaris Market Research. Ablation is treatment for the destruction of liver tumors without removing them. These technique is used in patients with few small tumors and when surgery is not a worthy option due to reduced liver function or poor health condition. These treatment is sometimes used in patients waiting for a liver transplant. Generally, tumor ablation is a minimally invasive surgical method to treat solid cancers. Special probes are used to freeze or burn cancers without the surgery. Ultrasound (US), Computed Tomography (CT), or Magnetic Resonance Imaging (MRI) are used to guide and position the needle probe into the tumor. The most common cancers treated by this method are lung cancer, liver cancer and kidney (renal) cancer. Other cancers can also be treated if the tumor cell are accessible to reach and of appropriate size

The global tumor ablation market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of tumor ablation for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional or traditional surgical procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the continual developments in ablation expertise, leading to the increased development of new and pioneering products that are the efficient, safe, and minimally invasive are also advancing towards significant growth of the global tumor ablation market.

With the increasing geriatric population, the demand for minimally invasive surgeries (MIS) is increasing globally. Through minimally intrusive surgeries, the patients result in faster recovery in comparison to conventional invasive procedures. Therefore, the demand for minimally invasive procedures such as radiofrequency ablation and cryoablation is increasing and thereby augmenting the global market growth.

The global tumor ablation market is segmented on the basis of type of technology, mode of treatment, and application. On the basis of type of technology, the global tumor ablation market is segmented into Radiofrequency (RF) ablation, Microwave ablation, Cryoablation, and others. The radiofrequency ablation is estimated to dominate the global tumor ablation market owing to its design of treating target tissues without causing damage to the surrounding healthy cells. However, microwave ablation technology is expected to grow at the rapid test rate in the upcoming years, due to increasing adoption of microwave tumor ablation among healthcare specialists.

On the basis of the type of technology, the global tumor ablation market is further categorized into surgical ablation, laparoscopic ablation, and percutaneous ablation. Moreover, on the basis of application the market is segmented into liver cancer, lung cancer, kidney cancer, bone metastasis, and others. Lung cancer is anticipated to grow with the fastest rate in the forecast period due to growing prevalence of lung cancer cases and increasing private as well as government investment to develop new lung cancer ablation products.

Some of the key players operating in global tumor ablation market are EDAP TMS S.A., St. Jude Medical Inc., BVM Medical Ltd., SonaCare Medical LLC, AngioDynamics Inc., Boston Scientific Corp., BTG International Ltd., Integra LifeSciences Holdings Corp., and Medtronic plc. among others.

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-aways
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Tumor Ablation Market Insights

  • 3.1. Tumor ablation- Industry snapshot
  • 3.2. Tumor ablation -Ecosystem analysis
  • 3.3. Tumor ablation market dynamics
    • 3.3.1. Tumor ablation- Market Forces
      • 3.3.1.1. Tumor ablation Market driver analysis
      • 3.3.1.2. Tumor ablation Market restraint/challenges analysis
      • 3.3.1.3. Tumor ablation Market opportunity analysis
    • 3.3.2. Industry analysis - Porter's five force
      • 3.3.2.1. Bargaining power of supplier
      • 3.3.2.2. Bargaining power of buyer
      • 3.3.2.3. Threat of substitute
      • 3.3.2.4. Threat of new entrant
      • 3.3.2.5. Degree of competition
    • 3.3.3. Tumor ablation market PEST analysis, 2019
    • 3.3.4. Value Chain Analysis
    • 3.3.5. Tumor ablation Industry trends
    • 3.3.6. Prevalence of tumor ablation

4. Tumor ablation Market Size and Forecast by type of technology

  • 4.1. Key findings
  • 4.2. Radiofrequency (RF) ablation
    • 4.2.1. Global market estimates and forecasts, 2020-2026
  • 4.3. Microwave ablation
    • 4.3.1. Global market estimates and forecasts, 2020-2026
  • 4.4. Cryoablation
    • 4.4.1. Global market estimates and forecasts, 2020-2026
  • 4.5. Others
    • 4.5.1. Global market estimates and forecasts, 2020-2026

5. Tumor ablation Market Size and Forecast by Mode of treatment

  • 5.1. Key findings
  • 5.2. Surgical ablation
    • 5.2.1. Global market estimates and forecasts, 2020-2026
  • 5.3. Laparoscopic ablation
    • 5.3.1. Global market estimates and forecasts, 2020-2026
  • 5.4. Percutaneous ablation
    • 5.4.1. Global market estimates and forecasts, 2020-2026

6. Tumor ablation Market Size and Forecast by Application

  • 6.1. Key findings
  • 6.2. Liver cancer
    • 6.2.1. Global market estimates and forecasts, 2020-2026
  • 6.3. Lung cancer
    • 6.3.1. Global market estimates and forecasts, 2020-2026
  • 6.4. Kidney cancer
    • 6.4.1. Global market estimates and forecasts, 2020-2026
  • 6.5. Bone metastasis
    • 6.5.1. Global market estimates and forecasts, 2020-2026
  • 6.6. Others
    • 6.6.1. Global market estimates and forecasts, 2020-2026

7. Tumor ablation Market Size and Forecast by Regions

  • 7.1. Key findings
  • 7.2. North America
    • 7.2.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
    • 7.2.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
    • 7.2.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.2.4. U.S.
      • 7.2.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.2.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.2.4.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.2.5. Canada
      • 7.2.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.2.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.2.5.3. Tumor ablation Market by application (USD Million), 2020-2026
  • 7.3. Europe
    • 7.3.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
    • 7.3.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
    • 7.3.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.3.4. Germany
      • 7.3.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.3.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.3.4.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.3.5. UK
      • 7.3.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.3.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.3.5.3. Tumor ablation Market by application (USD Million), 2020-2026
  • 7.4. Asia Pacific
    • 7.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
    • 7.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
    • 7.4.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.4.4. China
      • 7.4.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.4.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.4.4.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.4.5. India
      • 7.4.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.4.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.4.5.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.4.6. Japan
      • 7.4.6.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.4.6.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.4.6.3. Tumor ablation Market by application (USD Million), 2020-2026
  • 7.5. Latin America
    • 7.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
    • 7.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
    • 7.5.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.5.4. Brazil
      • 7.5.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.5.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.5.4.3. Tumor ablation Market by application (USD Million), 2020-2026
    • 7.5.5. Mexico
      • 7.5.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
      • 7.5.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
      • 7.5.5.3. Tumor ablation Market by application (USD Million), 2020-2026
  • 7.6. Middle East & Africa
    • 7.6.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026
    • 7.6.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026
    • 7.6.3. Tumor ablation Market by application (USD Million), 2020-2026

8. Company Profiles

  • 8.1. EDAP TMS S.A.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Type Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. Jude Medical Inc.
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Type Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. BVM Medical Ltd.
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Type Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. SonaCare Medical LLC
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Type Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. AngioDynamics Inc.
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Type Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. Boston Scientific Corp.
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Type Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Pacific Biosciences of California, Inc
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Type Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. BTG International Ltd.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Type Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. Integra Life Sciences Holdings Corp.
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Type Benchmarking
  • 8.10. Medtronic plc.
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Type Benchmarking
    • 8.10.4. Recent Developments